20
Arevipharma Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is KETAMINE HYDROCHLORIDE, with a corresponding US DMF Number 29094.
Remarkably, this DMF maintains an Active status since its submission on April 14, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 06, 2016, and payment made on April 16, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II